Protagonist Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Protagonist Therapeutics Inc
TickerPTGX
CIK #0001377121
CUSIP74366E102
SectorLife Sciences - Pharmaceutical Preparations
Address521 Cottonwood Drive, Suite 100, Malpitas, CA 95035-7404
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Protagonist Therapeutics Inc 2015-07-24 17.5 M Exemption: 506(b) · Remaining: $22,500,001 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001377121] 10-K
[0001377121] 10-Q
[0001377121] 3
[0001377121] 4
[0001377121] 5
[0001377121] 8-K
[0001377121] D
[0001377121] SC 13D
[0001377121] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
State Street Corp Protagonist Therapeutics Inc [2026-05-12] 0.0
Vanguard Capital Management LLC Protagonist Therapeutics Inc [2026-04-30] 0.0
Vanguard Portfolio Management LLC Protagonist Therapeutics Inc [2026-04-29] 0.0
Wellington Management Group LLP Protagonist Therapeutics Inc [2026-02-10] 0.0
State Street Corp Protagonist Therapeutics Inc [2025-08-11] 0.0
Biotechnology Value Fund L P Protagonist Therapeutics Inc [2025-06-16] 0.0
State Street Corp Protagonist Therapeutics Inc [2025-05-13] 0.0
Deep Track Capital LP Protagonist Therapeutics Inc [2025-04-10] 0.0
State Street Corp Protagonist Therapeutics Inc [2024-10-16] 5.4
Point72 Asset Management LP Protagonist Therapeutics Inc [2023-12-18] 5.5
Adage Capital Partners GP LLC Protagonist Therapeutics Inc [2023-04-13] 5.44
Biotechnology Value Fund L P Protagonist Therapeutics Inc [2023-03-20] 5.1
Vanguard Group Inc Protagonist Therapeutics Inc [2023-02-09] 6.3
Citadel Advisors LLC Protagonist Therapeutics Inc [2023-01-03] 3.6
State Street Corp Protagonist Therapeutics Inc [2022-02-10] 5.39
Point72 Asset Management LP Protagonist Therapeutics Inc [2021-09-21] 0.1
Consonance Capital Management LP Protagonist Therapeutics Inc [2021-02-17] 5.75
Consonance Capital Management LP Protagonist Therapeutics Inc [2021-02-16] 5.75
BlackRock Inc Protagonist Therapeutics Inc [2021-02-02] 6.2
Adage Capital Partners GP LLC Protagonist Therapeutics Inc [2020-05-22] 6.39
BlackRock Inc Protagonist Therapeutics Inc [2020-02-07] 5.7
RTW Investments LP Protagonist Therapeutics Inc [2019-12-16] 8.04
Integrated Core Strategies US LLC Protagonist Therapeutics Inc [2019-07-01] 3.5
Venrock Healthcare Capital Partners II LP Protagonist Therapeutics Inc [2019-06-17] 6.4
Perceptive Advisors LLC Protagonist Therapeutics Inc [2018-12-10] 5.3
Farallon Capital Management LLC Protagonist Therapeutics Inc [2018-08-20] 1.9
Great Point Partners LLC Protagonist Therapeutics Inc [2018-07-02] 6.95
Biotechnology Value Fund L P Protagonist Therapeutics Inc [2018-05-24] 3.4
Pharmstandard International Sa Protagonist Therapeutics Inc [2017-02-13] 5.88
Canaan X LP Protagonist Therapeutics Inc [2017-01-26] 14.7
FMR LLC Protagonist Therapeutics Inc [2016-10-11] 0.0
Aisling Capital IV LP Protagonist Therapeutics Inc [2016-09-12] 5.1
Lilly Ventures Fund I LLC Protagonist Therapeutics Inc [2016-08-26] 12.9
RA Capital Management LLC Protagonist Therapeutics Inc [2016-08-25] 6.8
Adage Capital Partners GP LLC Protagonist Therapeutics Inc [2016-08-19] 0.69
Johnson & Johnson Protagonist Therapeutics Inc [2016-08-19] 15.0
Form 3/4/5 Filer 2011 - 2026
Waddill William D
Protagonist Therapeutics Inc
Patel Dinesh V Ph D
Giraudo Bryan
Ali Asif
Molina Arturo MD
Selick Harold E
Williams Lewis T
O'Dowd Sarah A
Gupta Suneel
Swisher Daniel N JR
Noonberg Sarah B
Liu David Y
Kalkofen Donald A
Saks Samuel R
Khosla Chaitan PhD
Shame Richard S
Murphy Niall
O'Neil Thomas P
Shanafelt Armen
Canaan Partners X LLC
Canaan X LP
Adage Capital Partners GP LLC
Adage Capital Partners LP
Adage Capital Advisors LLC
Atchinson Robert
Gross Phillip
Grant Julie Papanek
Hodder William A
Johnson & Johnson
Johnson & Johnson Development Corp ET AL
LV Management Group LLC
Hall Steven Edward
Torres S Edward
Lilly Ventures Fund I LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Selick Harold E
Common Stock
2026-03-26 Option exercise 24,000 $12.88 309,120
Ali Asif
Stock Option (right to buy) · derivative
2026-03-26 Option exercise 5,265 $0.00
Molina Arturo MD
Common Stock
2026-03-26 Sell 15,000 $104.79 1,571,850
Ali Asif
Common Stock
2026-03-26 Option exercise 5,265 $12.17 64,075
Ali Asif
Stock Option (right to buy) · derivative
2026-03-26 Option exercise 19,500 $0.00
Ali Asif
Common Stock
2026-03-26 Sell 24,765 $104.24 2,581,504
Selick Harold E
Stock Option (right to buy) · derivative
2026-03-26 Option exercise 24,000 $0.00
Molina Arturo MD
Stock Option (right to buy) · derivative
2026-03-26 Option exercise 15,000 $0.00
Molina Arturo MD
Common Stock
2026-03-26 Option exercise 15,000 $8.04 120,600
Selick Harold E
Common Stock
2026-03-26 Sell 24,000 $105.00 2,520,000
Ali Asif
Common Stock
2026-03-26 Option exercise 19,500 $19.19 374,205
Patel Dinesh V Ph D
Common Stock
2026-03-25 Sell 54,641 $101.00 5,518,741
Patel Dinesh V Ph D
Stock Option (right to buy) · derivative
2026-03-25 Option exercise 54,641 $0.00
Patel Dinesh V Ph D
Common Stock
2026-03-25 Option exercise 54,641 $8.58 468,820
Patel Dinesh V Ph D
Stock Option (right to buy) · derivative
2026-03-24 Option exercise 59 $0.00
Patel Dinesh V Ph D
Common Stock
2026-03-24 Sell 59 $101.00 5,959
Patel Dinesh V Ph D
Common Stock
2026-03-24 Option exercise 59 $8.58 506
Patel Dinesh V Ph D
Common Stock
2026-03-23 Gift 50,000 $0.00
Williams Lewis T
Stock Option (right to buy) · derivative
2026-02-17 Option exercise 18,000 $0.00
Williams Lewis T
Common Stock
2026-02-17 Option exercise 18,000 $10.84 195,120
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 322 77,309,440
2025-12-31 320 69,876,519
2025-09-30 276 69,414,865
2025-06-30 276 70,210,363
2025-03-31 281 64,747,178
2024-12-31 244 62,852,317
2024-09-30 243 61,020,419
2024-06-30 192 58,212,393
2024-03-31 186 63,109,591
2023-12-31 157 58,743,418
2023-09-30 145 56,410,922
2023-06-30 172 57,633,692
Form 13F Holdings
Firm Period DFND Voting Shares
Moody Aldrich Partners LLC [2026-06-30] SOLE 28,138 59,601
Alaska Retirement Management Board [2026-06-30] SOLE 28,084 28,084
Louisiana State Employees Retirement System [2026-06-30] SOLE 26,100 26,100
Yousif Capital Management LLC [2026-06-30] SOLE 4,252 16,483
Commonwealth of Pennsylvania Public School Empls Retrmt SYS [2026-06-30] SOLE 14,335 14,335
Franklin Street Advisors Inc /NC [2026-06-30] DFND 12,650 12,810
Cache Advisors LLC [2026-06-30] SOLE 10,143 10,143
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 12 3,958
Crossmark Global Holdings Inc [2026-06-30] SOLE 3,389 3,389
Gamma Investing LLC [2026-06-30] DFND 3,109 3,109
Burney CO/ [2026-06-30] DFND 3,054 3,054
PSP Research LLC [2026-06-30] SOLE 0 3,000
Connecticut Capital Management Group LLC [2026-06-30] OTR 0 1,736
Harbor Investment Advisory LLC [2026-06-30] SOLE 724 724
Farther Finance Advisors LLC [2026-06-30] SOLE 0 442
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 131 131
Burney CO/ [2026-06-30] SOLE 0 125
Cedar Mountain Advisors LLC [2026-06-30] SOLE 0 113
Wolff Wiese Magana LLC [2026-06-30] SOLE 35 35
Farmers & Merchants Investments Inc [2026-06-30] SOLE 35 35
Torren Management LLC [2026-06-30] SOLE 0 30
Marquette Asset Management LLC [2026-06-30] SOLE 0 28
Versant Capital Management Inc [2026-06-30] SOLE 27 27
Handelsbanken Fonder AB [2026-06-30] SOLE 0 21
Physician Wealth Advisors Inc [2026-06-30] SOLE 0 19
JFS Wealth Advisors LLC [2026-06-30] SOLE 0 9
Hughes Financial Services LLC [2026-06-30] SOLE 8 8
Noble Wealth Management PBC [2026-06-30] SOLE 8 8
Trust Co [2026-06-30] SOLE 7 7
Ares Financial Consulting LLC [2026-06-30] SOLE 6 6
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com